Growth Story Still Intact For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $4.22, with 6.97 million shares of worth about $29.42 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 34.82% during that period and on July 09, 2025 the price saw a […]
Value Hunters: Look To AbCellera Biologics Inc (ABCL)
Currently, there are 298.36M common shares owned by the public and among those 223.95M shares have been available to trade. The company’s stock has a 5-day price change of 16.46% and 42.08% over the past three months. ABCL shares are trading 25.17% year to date (YTD), with the 12-month market performance up to 25.60% higher. […]
AbCellera Biologics Inc (ABCL): Street Finally Waking Up
Currently, there are 298.36M common shares owned by the public and among those 223.95M shares have been available to trade. The company’s stock has a 5-day price change of 3.31% and 32.77% over the past three months. ABCL shares are trading 6.48% year to date (YTD), with the 12-month market performance down to -6.31% lower. […]
AbCellera Biologics Inc (ABCL) Outlook Starting To Look Brighter?
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $3.23, with 20.07 million shares of worth about $64.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.67% during that period and on June 11, 2025 the price saw a […]
Some Investing Thoughts On AbCellera Biologics Inc (NASDAQ: ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $2.42, with 4.05 million shares of worth about $9.8 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.60% during that period and on June 04, 2025 the price saw a […]